Hit to lead
Hit to Lead (H2L) is a process in Drug Discovery and Pharmacology that involves the identification of active, but chemically simple compounds, and their subsequent refinement into more potent and selective chemical entities. This process is a critical step in the development of new Medicinal Drugs.
Overview[edit | edit source]
The Hit to Lead process begins with the identification of a 'hit', a compound that demonstrates some level of activity against a chosen Biological Target. This hit is typically identified through High-Throughput Screening (HTS) of large libraries of compounds. Once a hit has been identified, it is then optimized through a process of Medicinal Chemistry to improve its potency, selectivity, and pharmacokinetic properties. This optimized compound is known as a 'lead'.
Hit Identification[edit | edit source]
Hit identification is the first step in the Hit to Lead process. This involves the screening of large libraries of compounds against a chosen biological target. The aim of this step is to identify compounds that show some level of activity against the target. This is typically achieved through the use of High-Throughput Screening (HTS), a process that allows for the rapid testing of large numbers of compounds.
Lead Optimization[edit | edit source]
Once a hit has been identified, it is then optimized to improve its potency, selectivity, and pharmacokinetic properties. This is achieved through a process of Medicinal Chemistry, which involves the systematic modification of the hit compound's chemical structure. The aim of this process is to produce a 'lead' compound that is suitable for further development.
Challenges[edit | edit source]
The Hit to Lead process is not without its challenges. One of the main challenges is the need to balance potency and selectivity with acceptable pharmacokinetic properties. This often requires a process of iterative design and testing, which can be time-consuming and costly. Additionally, the process is often complicated by the need to consider potential Toxicity and Side Effects of the lead compound.
See Also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD